May, 03 2025 Saturday 20:27 Hrs
  • SENSEX :   80,501.99

  • Commodity broking firm in India259.75( 0.32%) 02-May-2025
top-arrow-market
Sensex 80501.99 259.75  (0.32) 02-May-2025
Previous Day Close
80242.24
Today's High/Low
High Low
  •  
  •  
81177.93 80168.59

Company News Details

Divis Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
532488
INE361B01024
513.6236355
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DIVISLAB
78.12
161949.11
EPS(TTM)
Face Value()
Div & Yield %
78.09
2
0.49
 

divis laboratories ltd
Divis Lab spurts as broker maintains buy call
Apr 24,2025
In its latest note, the broker highlighted Divi’s strong potential to emerge as a primary supplier, backed by ongoing capacity expansion. It also noted the addition of Orforglipron—Eli Lilly’s promising oral GLP-1 candidate—to Divi’s development pipeline. The report further anticipates additional rounds of capital expenditure as product volumes scale up through 2030.

Divi's is engaged in manufacturing of generic APIs, custom synthesis of active ingredients for innovator companies, other specialty chemicals and nutraceuticals. The company is focused on export markets within the domain of its capabilities.

Divi’s Laboratories' consolidated net profit surged 64.53% to Rs 589 crore on 25.01% rise in revenue from operations to Rs 2,319 crore in Q3 FY25 over Q3 FY24.

Top
Attention Investor:
Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers/Depository Participant.     KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, ,Mutual ).    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.